Peer-influenced content. Sources you trust. No registration required. This is HCN.
The Epoch Times
Recent CDC findings have confirmed the first known cases of HIV transmission through nonsterile microneedling procedures at an unlicensed spa, highlighting significant lapses in infection control practices.
Dermatology May 3rd 2024
Cleveland Clinic Journal of Medicine
Early adjunctive corticosteroids in PJP management can be lifesaving for HIV-positive patients with hypoxemia, but their efficacy in HIV-negative patients warrants further investigation.
Infectious Diseases April 29th 2024
TheBodyPro
The “Effectiveness of PrEPTECH” trial reveals telehealth’s potential and challenges in initiating and sustaining PrEP adherence among at-risk groups, emphasizing the necessity for integrated community support in healthcare strategies.
Infectious Diseases April 22nd 2024
Infectious Disease Advisor
MySTIRisk’s AI-driven analysis offers a nuanced approach to identifying patients at heightened risk for STIs, providing a crucial tool in optimizing healthcare strategies and interventions in sexual health clinics.
Infectious Diseases March 25th 2024
Pharmacy Today
Pharmacists are emerging as key players in expanding PrEP access, offering a unique opportunity to close the gap in HIV prevention. Learn how this shift could help us meet national HIV prevention goals.
Clinical Pharmacology September 29th 2023
The New England Journal of Medicine
The recent phase 3 trial on pitavastatin’s effectiveness in HIV-infected patients opens new avenues in cardiovascular disease prevention within this demographic. Physicians may find the detailed insights on risk reduction and side effects beneficial in tailoring personalized care strategies.
Allergy & Immunology July 31st 2023